Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 171

1.

Histologic variation in the skin lesions of the glucagonoma syndrome.

Kheir SM, Omura EF, Grizzle WE, Herrera GA, Lee I.

Am J Surg Pathol. 1986 Jul;10(7):445-53.

PMID:
3014912
2.

Glucagonoma syndrome.

Hashizume T, Kiryu H, Noda K, Kano T, Nakano R.

J Am Acad Dermatol. 1988 Aug;19(2 Pt 2):377-83.

PMID:
2842381
3.

Glucagonoma syndrome. A clinicopathologic, immunocytochemical, and ultrastructural study.

Vandersteen PR, Scheithauer BW.

J Am Acad Dermatol. 1985 Jun;12(6):1032-9.

PMID:
2989344
4.

A postmortem study of malignant glucagonoma with heart muscle hypertrophy, including chemical, histochemical, immunohistological and ultrastructural observations.

Takemiya M, Miyayama H, Takeya M, Takeuchi T, Konno T, Kitoh M, Fukushima H.

Hum Pathol. 1981 Nov;12(11):988-99.

PMID:
6274784
5.

[The glucagonoma syndrome].

Rappersberger K, Wolff-Schreiner E, Konrad K, Wolff K.

Hautarzt. 1987 Oct;38(10):589-98. German.

PMID:
2824404
6.

Glucagonoma syndrome: case report and literature review.

Parker CM, Hanke CW, Madura JA, Liss EC.

J Dermatol Surg Oncol. 1984 Nov;10(11):884-9.

PMID:
6092443
7.

[Glucagonoma syndrome with normal blood glucagon ].

Quencez E, Zultak M, Blanc D, Gillet M, Laurent R.

Ann Dermatol Venereol. 1987;114(9):1103-8. French. No abstract available.

PMID:
2829690
8.

[Glucagonoma syndrome].

Tellechea O, Baptista AP.

Acta Med Port. 1988 Mar-Apr;1(2):149-52. Review. Portuguese. No abstract available.

9.

The glucagonoma syndrome.

Shupack JL, Berczeller PH, Stevens DM.

J Dermatol Surg Oncol. 1978 Mar;4(3):242-7.

PMID:
204668
11.
12.

Clinical experience in diagnosis and treatment of glucagonoma syndrome.

Zhang M, Xu X, Shen Y, Hu ZH, Wu LM, Zheng SS.

Hepatobiliary Pancreat Dis Int. 2004 Aug;3(3):473-5. Review.

PMID:
15313692
13.

Glucagonoma tumors and syndrome.

Montenegro-Rodas F, Samaan NA.

Curr Probl Cancer. 1981 Dec;6(6):1-54. Review. No abstract available.

PMID:
6276079
14.

Nesidioblastosis and hyperplasia of alpha cells, microglucagonoma, and nonfunctioning islet cell tumor of the pancreas: review of the literature.

Yu R, Nissen NN, Dhall D, Heaney AP.

Pancreas. 2008 May;36(4):428-31. doi: 10.1097/MPA.0b013e31815ceb23.

PMID:
18437091
15.

Necrolytic migratory erythema.

Kovács RK, Korom I, Dobozy A, Farkas G, Ormos J, Kemény L.

J Cutan Pathol. 2006 Mar;33(3):242-5.

PMID:
16466513
16.

Glucagon-producing pancreatic endocrine tumors in two dogs with superficial necrolytic dermatitis.

Gross TL, O'Brien TD, Davies AP, Long RE.

J Am Vet Med Assoc. 1990 Dec 15;197(12):1619-22.

PMID:
2276959
17.

The glucagonoma syndrome--report of a case without overt diabetes.

Leibovici V, Granot E, Eid A, Goldin E, Okon E.

J Dermatol. 1987 Oct;14(5):491-6. No abstract available.

PMID:
2830323
18.

Glucagonoma syndrome demonstrating giant duodenal villi.

Stevens FM, Flanagan RW, O'Gorman D, Buchanan KD.

Gut. 1984 Jul;25(7):784-91.

19.

Glucagonoma syndrome. Report of two cases and literature review.

Binnick AN, Spencer SK, Dennison WL Jr, Horton ES.

Arch Dermatol. 1977 Jun;113(6):749-54.

PMID:
194536
20.

Effect of somatostatin on skin lesions and concentrations of plasma amino acids in a patient with glucagonoma-syndrome.

Schmid R, Allescher HD, Schepp W, Hölscher A, Siewert R, Schusdziarra V, Classen M.

Hepatogastroenterology. 1988 Feb;35(1):34-7.

PMID:
2896149

Supplemental Content

Support Center